During his keynote address at the Genetics Society of America: Model Organisms to Human Biology meeting in Boston this week, National Institute of General Medical Sciences director Jeremy Berg spoke about advances in pharmacogenomics related to warfarin dosing, the recent NIH-wide changes to grant applications, and NIGMS genetics and genomics resources for those who study model organisms, "from A to Z — from Arabidopsis to zebrafish." Berg also spoke about how investigators who use model organisms in their work might be most likely to receive NIGMS funding for their work.